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Congenital myopathy has recently been associated with biallelic pathogenic variants in the
SCN4A gene that encodes the voltage-dependent sodium channel NaV1.4.
1,2 In 13 previously
reported cases,1,2 7 died in utero or shortly after birth. The 6 survivors showed features con-
sistent with “classical” congenital myopathy. Here, we report 2 new familial cases with variable
phenotype.
Written informed consent was obtained from both patients. Permission for the study was
granted by the Danish Data Protection Agency.
The index patient, an 18-year-old woman, born as the second of 2 children to consanguineous
parents, reported weakness and dyspnea from early childhood. Pregnancy and birth were
normal, but postpartum, she had dysphagia and was tube fed. Early motor milestones were
delayed, with independent ambulation achieved at age 2.25 years and inability to lift her head
from a supine position until age 3 years. She experienced improvement in her condition
throughout childhood, but still had reduced walking distance (2.5 km), diﬃculty lifting heavy
objects, and experienced patella luxations.
On examination, the patient is 150 cm tall and has a dolichocephalic head shape and elbow
hypermobility (ﬁgure 1A). Strength testing showed diﬀuse muscle force reduction at Medical
ResearchCouncil (MRC) grade 4, with no distal/proximal gradient, and axial weakness. Spirometry
showed normal forced vital capacity (FVC) (88%) and forced expiratory volume (FEV1) (96%).
Creatine kinase (CK) levels and neurophysiologic ﬁndings were normal. Replacement of
muscle by fat on MRI was pronounced in gluteus maximus and hamstring muscles (ﬁgure 1B).
Muscle biopsy, at age 4 years, displayed myopathic features with varying ﬁber size, increased
number of internalized nuclei, atrophic ﬁbers, and endomysial ﬁbrosis and fat inﬁltration.
Next-generation sequencing revealed homozygosity for a previously described missense variant
in SCN4A (NM_000334.4: c.3425G>A(p.Arg.1142Gln)),2 conﬁrmed through Sanger se-
quencing, and was deemed to be pathogenic by 6 prediction tools. Parents were heterozygous
for the variant.
The 22-year-old sister of the index patient was also homozygous for Arg1142Gln. She had
milder muscular complaints than her sister, which included diﬃculties lifting her head when
lying down, exertional shortness of breath, and poor cycling capacity since childhood. She had
elbow joint hypermobility like her sister. Her motor milestones were normal. Strength testing
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Figure 1 Clinical features in sisters with SCN4A congenital myopathy
Featuring the dococephalic head form in the index
patient (left image) andhypermobility of the elbows in
both sisters (middle and right image) (A). T1-weighted
muscle MRI images of the index patient show severe
fatty infiltration and atrophy of gluteus medius
(arrows, left image) and adductor magnus and, to
a lesser degree, the hamstrings bilaterally (right im-
age) (B).
Figure 2 The mutation R1142Q causes loss-of-function of NaV1.4 current
(A) Representative current traces for
NaV1.4 WT and R1142Q recorded
from transiently transfected
HEK293 cells. (B) I/V relationship for
the peak current density for NaV1.4
WT (n = 9) and R1142Q (n = 8).
Voltage protocol shown as inset. (C)
Steady-state inactivation and acti-
vation curves for NaV1.4 WT (black)
and R1142Q (gray). Voltage protocol
shown as inset. (D) Comparison of
activation V50 values between
NaV1.4 WT (black) and R1142Q
(gray). *p < 0.05; **p < 0.006; ****p
< 0.0001.
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showed reduced neck ﬂexion (MRC 4+), shoulder abduction
(MRC4+), and hip ﬂexion (MRC 4+). CK, lung function
tests, and MRI of thigh muscles were normal.
Functional assessment of the Arg1142Gln (R1142Q) variant in
human embryonic kidney 293 (HEK293) cells revealed partial
loss-of-function eﬀects (ﬁgure 2), as previously reported in
SCN4A-related congenital myopathy.1,2 NaV1.4 R1142Q peak
current density was signiﬁcantly lower than wild type (WT)
(WT: 106.4 ± 12.4 pA/pF, R1142Q: −39.0 ± 6.4 pA/pF at
5 mV, ﬁgure 2, A and B), and the voltage dependence of channel
activation was signiﬁcantly changed (ﬁgure 2, C and D).
Variants in SCN4A were originally linked to congenital
myasthenia,3,4 but recently, also to severe fetal hypokinesia and
early lethality1 and to sudden infant death syndrome.5 A
strikingly milder phenotype of “classical” congenital myopathy
has been described in 6 patients with SCN4A variants in a re-
cessive pattern, only 3 of whom were adults (aged 18–35 years
old).1,2 Our 18-year-old index patient exhibited a phenotype
similar to that previously reported,1 while her 20-year-old sister
was only marginally aﬀected. Our index patient’s characteristic
muscle MRI ﬁndings were similar to 4 other patients with
SCN4A mutations, including 2 brothers, compound hetero-
zygous for c.3425G>A(p.Arg1142Gln) and another missense
variant c.1123T>C (p.Cys375Arg).1,2 The brothers, unlike our
patients, had elongated faces, ptosis, facial weakness, scoliosis,
and elevated CK.2 We speculate whether homozygosity for the
p.Arg1142Gln variant conferred the milder phenotype ob-
served in our patients. The present report expands our
knowledge regarding SCN4A-related congenital myopathy in
adulthood and underscores that the phenotype of this disorder
may vary considerably, even within members of the same
family, as in other recessive channelopathies aﬀectingmuscles.6
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